ABUS

#2566
Arbutus Biopharma Corporation Common Stock
4.35 USD
-0.46%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
4.35
4.35
Intervallo Annuale
2.94
5.10
Variazione giornaliera
-0.46%
Variazione Mensile
+1.16%
Variazione di 6 mesi
+2.59%
Variazione Annuale
+32.62%
Chiusura Precedente
4.37
Apertura
4.35
Bid
Ask
Minimo
4.35
High
4.35
Volume
83
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Notizie